MAF1 and breast cancer: TANK, PPIA, ARHGAP17, CENPN, DSC2, MAF1, SLMAP, NCOA6, MED24, RCCD1, and HNRNPA2B1 that experience alterations must be specifically examined as they may be related to the advancement of breast cancer (Figure 4E).